Our governance - ARC Foundation for Cancer Research

270 volunteer members contribute to the governance of our foundation, working alongside a team of nearly 60 staff members in the fight against cancer.

Our Governance Philosophy

Donations Inspire Accountability

Our work is built entirely on charitable giving, and we never lose sight of this. The primary objective of our governance is to transform the generosity of donors and legators into meaningful action for research and patients.
Encouraging Open Dialogue

Listening to all viewpoints and welcoming diverse perspectives: our collaborative structure is designed to foster exchange, enable constructive debate and arrive at the best possible decisions. Collective intelligence advances research.
Science Comes First

Our scientific priorities evolve alongside new advances and emerging challenges. To make the most effective strategic choices in the fight against cancer, our governance relies on our Scientific Advisory Board, which identifies the most promising projects and ensures the relevance of funded research.

Our Organisational Structure

The Board of Trustees

12 volunteer members across 3 colleges, wholly dedicated to the governance of ARC Foundation. Learn more about our accreditation

The Executive Committee

4 members responsible for examining and preparing matters submitted to the Board of Trustees, particularly budget-related issues. Learn more about our accreditation

The Executive Leadership

Budget, accounts, fundraising activities, communications, HR policy... Working with the Executive Committee, the leadership team takes the necessary measures to ensure the smooth operation of ARC Foundation. Learn more about our accreditation

The Scientific Advisory Board

A crucial body for selecting research projects funded by ARC Foundation and monitoring their progress, following expert review by 5 national thematic committees. Learn more about our accreditation

The Research Strategy Committee

Its mission: to study research developments and emerging trends in order to shape  andadvance ARC Foundation's scientific strategy. Learn more about our accreditation

The Finance Committee

Its role: to propose investment policies for ARC Foundation's assets to the Board of Trustees and to monitor their implementation. Learn more about our accreditation

The Governance Committee

It prepares the work of the Board of Trustees on matters relating to governance. Learn more about our accreditation

The Audit Committee

Its mission is to evaluate and independently monitor both financial and non-financial risks to which ARC Foundation is exposed. Learn more about our accreditation

The Legal Committee

All legal matters concerning ARC Foundation's interests, including the management of legacy and donation cases, are handled by this committee. Learn more about our accreditation

The Development Committee

Its function: to propose the broad strategic direction for ARC Foundation's communications and fundraising activities. Learn more about our accreditation

The International Clinical Research Committee

Its mission is to review and monitor major clinical research programmes submitted to ARC Foundation, whether unsolicited or in response to calls for proposals. Learn more about our accreditation

Key Question: How does ARC Foundation ensure donations and legacies are used appropriately?

Through external audits and annual certification by independent auditors. Furthermore, ARC Foundation has been a member of the Comité de la Charte du Don en Confiance (the French Responsible Giving Charter Committee) since 1999. This accreditation, awarded by a non-profit organisation, is an essential guarantee in France for safeguarding donors' and legacy donors' contributions. Since that date, the Foundation has successfully renewed its accreditation every year.

Learn more about our accreditation

Donations Drive Research Forward

Support US - Donate

Why Give ?

Faces of Research

Who are they? What do they do? What are their research areas? Through a quick-fire questionnaire, our researchers reveal their work.

Dr Jean-Philippe Girard

Yellow, like the optimism linked to the immense progress made in cancer treatment over the last 15 years, particularly thanks to the arrival of immunotherapies.
Dr Victor Appay

Blue like the horizon of research if we manage to identify predictive cancer biomarkers related to immune ageing.
Researcher Marc Billaud

BLUE LIKE THE HORIZON OF RESEARCH if we agree to give a central place to prevention, which must be at the heart of health policies in oncology
Prof. Maha Ayyoub

Rose at the joy of having contributed to paving the way for personalised cancer vaccines, having worked for years on tumour antigen-specific lymphocytes.